このアイテムのアクセス数: 22
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
j.adro.2024.101669.pdf | 2.85 MB | Adobe PDF | 見る/開く |
タイトル: | Delta-Radiomics Approach Using Contrast-Enhanced and Noncontrast-Enhanced Computed Tomography Images for Predicting Distant Metastasis in Patients With Borderline Resectable Pancreatic Carcinoma |
著者: | Adachi, Takanori ![]() ![]() ![]() Nakamura, Mitsuhiro ![]() ![]() Iwai, Takahiro Yoshimura, Michio ![]() ![]() ![]() Mizowaki, Takashi ![]() ![]() ![]() |
著者名の別形: | 足立, 孝則 中村, 光宏 岩井, 貴寛 吉村, 通央 溝脇, 尚志 |
発行日: | Jan-2025 |
出版者: | Elsevier BV |
誌名: | Advances in radiation oncology |
巻: | 10 |
号: | 1 |
論文番号: | 101669 |
抄録: | PURPOSE: To predict distant metastasis (DM) in patients with borderline resectable pancreatic carcinoma using delta-radiomics features calculated from contrast-enhanced computed tomography (CECT) and non-CECT images. METHODS AND MATERIALS: Among 250 patients who underwent radiation therapy at our institution between February 2013 and December 2021, 67 patients were deemed eligible. A total of 11 clinical features and 3906 radiomics features were incorporated. Radiomics features were extracted from CECT and non-CECT images, and the differences between these features were calculated, resulting in delta-radiomics features. The patients were randomly divided into the training (70%) and test (30%) data sets for model development and validation. Predictive models were developed with clinical features (clinical model), radiomics features (radiomics model), and a combination of the abovementioned features (hybrid model) using Fine-Gray regression (FG) and random survival forest (RSF). Optimal hyperparameters were determined using stratified 5-fold cross-validation. Subsequently, the developed models were applied to the remaining test data sets, and the patients were divided into high- or low-risk groups based on their risk scores. Prognostic power was assessed using the concordance index, with 95% CIs obtained through 2000 bootstrapping iterations. Statistical significance between the above groups was assessed using Gray's test. RESULTS: At a median follow-up period of 23.8 months, 47 (70.1%) patients developed DM. The concordance indices of the FG-based clinical, radiomics, and hybrid models were 0.548, 0.603, and 0.623, respectively, in the test data set, whereas those of the RSF-based models were 0.598, 0.680, and 0.727, respectively. The RSF-based model, including delta-radiomics features, significantly divided the cumulative incidence curves into two risk groups (P < .05). The feature map of the gray-level size-zone matrix showed that the difference in feature values between CECT and non-CECT images correlated with the incidence of DM. CONCLUSIONS: Delta-radiomics features obtained from CECT and non-CECT images using RSF successfully predict the incidence of DM in patients with borderline resectable pancreatic carcinoma. |
著作権等: | © 2024TheAuthor(s). Published by Elsevier Inc. on behalf of American Society for Radiation Oncology. This is an open access article under the CC BY-NC-ND license. |
URI: | http://hdl.handle.net/2433/291482 |
DOI(出版社版): | 10.1016/j.adro.2024.101669 |
PubMed ID: | 39687476 |
出現コレクション: | 学術雑誌掲載論文等 |

このアイテムは次のライセンスが設定されています: クリエイティブ・コモンズ・ライセンス